A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis. Read more about A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis.
A longitudinal big data approach for precision health. Read more about A longitudinal big data approach for precision health.
Publisher Correction: Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency. Read more about Publisher Correction: Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency.
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma. Read more about Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.
Translation control of the immune checkpoint in cancer and its therapeutic targeting. Read more about Translation control of the immune checkpoint in cancer and its therapeutic targeting.
Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency. Read more about Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency.
Publisher Correction: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma. Read more about Publisher Correction: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma.
Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer. Read more about Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer.
Cancer cells exploit an orphan RNA to drive metastatic progression. Read more about Cancer cells exploit an orphan RNA to drive metastatic progression.
